149 related articles for article (PubMed ID: 23535901)
1. Serum phospholipid fatty acids, genetic variation in myeloperoxidase, and prostate cancer risk in heavy smokers: a gene-nutrient interaction in the carotene and retinol efficacy trial.
Cheng TY; King IB; Barnett MJ; Ambrosone CB; Thornquist MD; Goodman GE; Neuhouser ML
Am J Epidemiol; 2013 May; 177(10):1106-17. PubMed ID: 23535901
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in myeloperoxidase modifies the association of serum α-tocopherol with aggressive prostate cancer among current smokers.
Cheng TY; Barnett MJ; Kristal AR; Ambrosone CB; King IB; Thornquist MD; Goodman GE; Neuhouser ML
J Nutr; 2011 Sep; 141(9):1731-7. PubMed ID: 21795425
[TBL] [Abstract][Full Text] [Related]
3. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort.
Choi JY; Neuhouser ML; Barnett MJ; Hong CC; Kristal AR; Thornquist MD; King IB; Goodman GE; Ambrosone CB
Carcinogenesis; 2008 May; 29(5):964-70. PubMed ID: 18296681
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk.
Chavarro JE; Stampfer MJ; Li H; Campos H; Kurth T; Ma J
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1364-70. PubMed ID: 17585059
[TBL] [Abstract][Full Text] [Related]
5. Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease.
Tefik T; Kucukgergin C; Sanli O; Oktar T; Seckin S; Ozsoy C
BJU Int; 2013 Aug; 112(4):E406-14. PubMed ID: 23773345
[TBL] [Abstract][Full Text] [Related]
6. Association of polymorphisms in FADS gene with age-related changes in serum phospholipid polyunsaturated fatty acids and oxidative stress markers in middle-aged nonobese men.
Hong SH; Kwak JH; Paik JK; Chae JS; Lee JH
Clin Interv Aging; 2013; 8():585-96. PubMed ID: 23818766
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers.
Choi JY; Neuhouser ML; Barnett M; Hudson M; Kristal AR; Thornquist M; King IB; Goodman GE; Ambrosone CB
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1115-20. PubMed ID: 17548672
[TBL] [Abstract][Full Text] [Related]
8. (n-6) PUFA increase and dairy foods decrease prostate cancer risk in heavy smokers.
Neuhouser ML; Barnett MJ; Kristal AR; Ambrosone CB; King I; Thornquist M; Goodman G
J Nutr; 2007 Jul; 137(7):1821-7. PubMed ID: 17585037
[TBL] [Abstract][Full Text] [Related]
9. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers.
Männistö S; Pietinen P; Virtanen MJ; Salminen I; Albanes D; Giovannucci E; Virtamo J
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1422-8. PubMed ID: 14693732
[TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase G-463A polymorphism and risk of lung and prostate cancer in a Turkish population.
Arslan S; Pinarbasi H; Silig Y
Mol Med Rep; 2011; 4(1):87-92. PubMed ID: 21461569
[TBL] [Abstract][Full Text] [Related]
11. Serum trans-fatty acids are associated with risk of prostate cancer in beta-Carotene and Retinol Efficacy Trial.
King IB; Kristal AR; Schaffer S; Thornquist M; Goodman GE
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):988-92. PubMed ID: 15824175
[TBL] [Abstract][Full Text] [Related]
12. Body mass index and prostate cancer risk in the Carotene and Retinol Efficacy Trial.
Bonn SE; Barnett MJ; Thornquist M; Goodman G; Neuhouser ML
Eur J Cancer Prev; 2019 May; 28(3):212-219. PubMed ID: 29521683
[TBL] [Abstract][Full Text] [Related]
13. Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.
Crowe FL; Appleby PN; Travis RC; Barnett M; Brasky TM; Bueno-de-Mesquita HB; Chajes V; Chavarro JE; Chirlaque MD; English DR; Gibson RA; Giles GG; Goodman GE; Henning SM; Kaaks R; King IB; Kolonel LN; Kristal AR; Neuhouser ML; Park SY; Severi G; Siddiq A; Stampfer MJ; Stattin P; Tangen CM; Tjønneland A; Trichopoulos D; Tumino R; Wilkens LR; Key TJ; Allen NE;
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25210201
[TBL] [Abstract][Full Text] [Related]
14. Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial.
Neuhouser ML; Barnett MJ; Kristal AR; Ambrosone CB; King IB; Thornquist M; Goodman GG
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2202-6. PubMed ID: 19661078
[TBL] [Abstract][Full Text] [Related]
15. Serum phytanic and pristanic acid levels and prostate cancer risk in Finnish smokers.
Wright ME; Albanes D; Moser AB; Weinstein SJ; Snyder K; Männistö S; Gann PH
Cancer Med; 2014 Dec; 3(6):1562-9. PubMed ID: 25132681
[TBL] [Abstract][Full Text] [Related]
16. Plasma eicosapentaenoic acid is negatively associated with all-cause mortality among men and women in a population-based prospective study.
Miura K; Hughes MCB; Ungerer JP; Green AC
Nutr Res; 2016 Nov; 36(11):1202-1209. PubMed ID: 27865614
[TBL] [Abstract][Full Text] [Related]
17. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.
Li H; Kantoff PW; Giovannucci E; Leitzmann MF; Gaziano JM; Stampfer MJ; Ma J
Cancer Res; 2005 Mar; 65(6):2498-504. PubMed ID: 15781667
[TBL] [Abstract][Full Text] [Related]
18. Association of serum phospholipid fatty acids with breast cancer risk among postmenopausal cigarette smokers.
Takata Y; King IB; Neuhouser ML; Schaffer S; Barnett M; Thornquist M; Peters U; Goodman GE
Cancer Causes Control; 2009 May; 20(4):497-504. PubMed ID: 19255861
[TBL] [Abstract][Full Text] [Related]
19. Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer.
Harvei S; Bjerve KS; Tretli S; Jellum E; Robsahm TE; Vatten L
Int J Cancer; 1997 May; 71(4):545-51. PubMed ID: 9178806
[TBL] [Abstract][Full Text] [Related]
20. Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium.
Khankari NK; Murff HJ; Zeng C; Wen W; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Donovan JL; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau SN; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; Zheng W;
Br J Cancer; 2016 Aug; 115(5):624-31. PubMed ID: 27490808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
